Three-Quarters of Members of “Expert” Medical Guideline Panels Have Ties to Drug Industry
By Noel Brinkerhoff | AllGov | August 17, 2013
The vast majority of medical experts in the U.S. who help formulate disease and diagnostic guidelines are taking money from the pharmaceutical industry, according to a new study.
